Literature DB >> 24862258

The metabolic alterations of cancer cells.

Marco Sciacovelli1, Edoardo Gaude1, Mika Hilvo2, Christian Frezza3.   

Abstract

Cancer cells exhibit profound metabolic alterations, allowing them to fulfill the metabolic needs that come with increased proliferation and additional facets of malignancy. Such a metabolic transformation is orchestrated by the genetic changes that drive tumorigenesis, that is, the activation of oncogenes and/or the loss of oncosuppressor genes, and further shaped by environmental cues, such as oxygen concentration and nutrient availability. Understanding this metabolic rewiring is essential to elucidate the fundamental mechanisms of tumorigenesis as well as to find novel, therapeutically exploitable liabilities of malignant cells. Here, we describe key features of the metabolic transformation of cancer cells, which frequently include the switch to aerobic glycolysis, a profound mitochondrial reprogramming, and the deregulation of lipid metabolism, highlighting the notion that these pathways are not independent but rather cooperate to sustain proliferation. Finally, we hypothesize that only those genetic defects that effectively support anabolism are selected in the course of tumor progression, implying that cancer-associated mutations may undergo a metabolically convergent evolution.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP; Glucose; Glutamine; Oncometabolism; Tumor suppressor; Warburg effect

Mesh:

Substances:

Year:  2014        PMID: 24862258     DOI: 10.1016/B978-0-12-416618-9.00001-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  38 in total

1.  FASNating targets of metformin in breast cancer stem-like cells.

Authors:  Elizabeth A Wellberg; Steven M Anderson
Journal:  Horm Cancer       Date:  2014-08-30       Impact factor: 3.869

2.  Systematic review and meta-analysis of studies assessing the relationship between statin use and risk of ovarian cancer.

Authors:  Sarah Irvin; Megan A Clarke; Britton Trabert; Nicolas Wentzensen
Journal:  Cancer Causes Control       Date:  2020-07-20       Impact factor: 2.506

3.  Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes.

Authors:  Shunsuke Kon; Kojiro Ishibashi; Hiroto Katoh; Sho Kitamoto; Takanobu Shirai; Shinya Tanaka; Mihoko Kajita; Susumu Ishikawa; Hajime Yamauchi; Yuta Yako; Tomoko Kamasaki; Tomohiro Matsumoto; Hirotaka Watanabe; Riku Egami; Ayana Sasaki; Atsuko Nishikawa; Ikumi Kameda; Takeshi Maruyama; Rika Narumi; Tomoko Morita; Yoshiteru Sasaki; Ryosuke Enoki; Sato Honma; Hiromi Imamura; Masanobu Oshima; Tomoyoshi Soga; Jun-Ichi Miyazaki; Michael R Duchen; Jin-Min Nam; Yasuhito Onodera; Shingo Yoshioka; Junichi Kikuta; Masaru Ishii; Masamichi Imajo; Eisuke Nishida; Yoichiro Fujioka; Yusuke Ohba; Toshiro Sato; Yasuyuki Fujita
Journal:  Nat Cell Biol       Date:  2017-04-17       Impact factor: 28.824

4.  UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.

Authors:  Yang Wang; Cong-Hui Wang; Yu-Fei Zhang; Liang Zhu; Hui-Min Lei; Ya-Bin Tang
Journal:  Metabolomics       Date:  2019-03-25       Impact factor: 4.290

Review 5.  Enzymatic and nonenzymatic protein acetylations control glycolysis process in liver diseases.

Authors:  Juan Li; Tongxin Wang; Jun Xia; Weilei Yao; Feiruo Huang
Journal:  FASEB J       Date:  2019-08-01       Impact factor: 5.191

6.  Mitochondrial Pyruvate Carriers are not Required for Adipogenesis but are Regulated by High-Fat Feeding in Brown Adipose Tissue.

Authors:  Jasmine A Burrell; Allison J Richard; William T King; Jacqueline M Stephens
Journal:  Obesity (Silver Spring)       Date:  2020-02       Impact factor: 5.002

7.  Nano-delivery of RAD6/Translesion Synthesis Inhibitor SMI#9 for Triple-negative Breast Cancer Therapy.

Authors:  Nadia Saadat; Fangchao Liu; Brittany Haynes; Pratima Nangia-Makker; Xun Bao; Jing Li; Lisa A Polin; Smiti Gupta; Guangzhao Mao; Malathy P Shekhar
Journal:  Mol Cancer Ther       Date:  2018-09-21       Impact factor: 6.261

8.  Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas.

Authors:  Silvia Darb-Esfahani; Elena Ioana Braicu; Mika Hilvo; Ines de Santiago; Peddinti Gopalacharyulu; Wolfgang D Schmitt; Jan Budczies; Marc Kuhberg; Manfred Dietel; Tero Aittokallio; Florian Markowetz; Carsten Denkert; Jalid Sehouli; Christian Frezza
Journal:  Cancer Res       Date:  2015-12-18       Impact factor: 12.701

9.  LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response.

Authors:  Ji Hee Ha; Rangasudhagar Radhakrishnan; Muralidharan Jayaraman; Mingda Yan; Jeremy D Ward; Kar-Ming Fung; Katherine Moxley; Anil K Sood; Ciro Isidoro; Priyabrata Mukherjee; Yong Sang Song; Danny N Dhanasekaran
Journal:  Cancer Res       Date:  2018-01-31       Impact factor: 12.701

Review 10.  Recent advances in the role of Th17/Treg cells in tumor immunity and tumor therapy.

Authors:  Yin Qianmei; Su Zehong; Wang Guang; Li Hui; Gaojian Lian
Journal:  Immunol Res       Date:  2021-07-24       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.